it stands as an innovative solution for managing severe hemorrhages and coagulopathies, reaffirming its position as a ...

The global hemostatic gels market is on a steady growth path, with its value projected to reach USD 1.9 billion by 2032. With rising surgical procedures, increasing trauma cases, and continuous ...

In January, Traumagel, a plant-based hemostatic gel that controls bleeding in seconds when applied to a wound at the point of care, saw its commercial release in the United States. The ...